Characterized by weakened or damaged heart musculature, heart failure results in the gradual buildup of fluid in a patient's lungs, legs, feet, and other parts of the body. The condition is chronic ...

What you need to know The prevalence of heart failure across Europe is estimated to be 1-2% of adults.1 In the UK, this places a substantial burden on patients and healthcare resources, including ...

Sarasota Memorial Hospital is part of a global research effort on an option to traditional cardiac resynchronization therapy.

Annual cardiologist visits for heart failure patients can reduce 1-year mortality by 6% to 9%, emphasizing the importance of specialist follow-up. The study identified disparities in cardiology care ...

New research indicates that the heart benefits of semaglutide can extend to those with heart failure. In a recent analysis from the SELECT trial, researchers reported that semaglutide 2.4 mg (Wegovy; ...

LONDON (Reuters) - Patients with heart failure who have had a heart attack but not had artery-clearing angioplasty treatment are less likely to die early if they take Sanofi-Aventis and Bristol-Myers ...

PITTSBURGH — There’s a global clinical trial underway for people suffering from heart failure. There are 400 patients in all and 80 cardiovascular centers taking part in the trial. Allegheny General ...

Milestone procedure gives young father with advanced heart failure a new heart and new future with his family.

Want to give your heart a little TLC? Across the country, nearly half of all adults have some form of cardiovascular disease, the leading cause of death for American men and women. With numbers like ...

A secondary analysis of the SOUL trial shows significant improvement in heart failure outcomes with oral semaglutide vs placebo, consistent with the injectable formulation.

Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...